Shields M - Search Results

1

Intentional removal of erroneously deployed coronary stents: A case series and review of the literature.

Ragosta M, Boehm R, Shields M, Taylor AM. Ragosta M, et al. Among authors: shields m. Catheter Cardiovasc Interv. 2021 Mar;97(4):670-674. doi: 10.1002/ccd.29256. Epub 2020 Aug 31. Catheter Cardiovasc Interv. 2021. PMID: 32865307 Review.

2

Characteristics and outcomes of surgically ineligible patients with multivessel disease treated with percutaneous coronary intervention.

Shields MC, Ouellette M, Kiefer N, Kohan L, Taylor AM, Ailawadi G, Ragosta M. Shields MC, et al. Catheter Cardiovasc Interv. 2021 Dec 1;98(7):1223-1229. doi: 10.1002/ccd.29508. Epub 2021 Feb 3. Catheter Cardiovasc Interv. 2021. PMID: 33533551

3

Association between circulating fibrocytes and angiographic coronary collaterals in patients with obstructive coronary artery disease.

Shields MC, Mehrad B, Keeley EC. Shields MC, et al. Am J Transl Res. 2018 Aug 15;10(8):2722-2725. eCollection 2018. Am J Transl Res. 2018. PMID: 30210709 Free PMC article.

4

Bioabsorbable Scaffolds: Can the Problems of Dissolution Be Overcome?

Shields MC, Goldberg S. Shields MC, et al. Cardiology. 2017;138(1):63-65. doi: 10.1159/000476058. Epub 2017 Jun 10. Cardiology. 2017. PMID: 28601882 No abstract available.

5

Intraaortic balloon pump versus percutaneous ventricular assist for the high-risk patient: keep it simple except when you can't.

Shields M, Goldberg S. Shields M, et al. J Invasive Cardiol. 2015 Mar;27(3):155-6. J Invasive Cardiol. 2015. PMID: 25740968 No abstract available.

6

Increased Afferent Nerve Firing Is Correlated With the Detection of Bladder Wall Micromotion in a Perfused Ex-Vivo Porcine Model.

Fogg RW, Ghatas MP, McCormack B, Shields M, Matthew AN, Grob G, Araia N, Burkett L, Speich JE, Klausner AP. Fogg RW, et al. Among authors: shields m. Neurourol Urodyn. 2025 Jan 13. doi: 10.1002/nau.25661. Online ahead of print. Neurourol Urodyn. 2025. PMID: 39803856

7

Synergistic learning with multi-task DeepONet for efficient PDE problem solving.

Kumar V, Goswami S, Kontolati K, Shields MD, Karniadakis GE. Kumar V, et al. Among authors: shields md. Neural Netw. 2025 Jan 3;184:107113. doi: 10.1016/j.neunet.2024.107113. Online ahead of print. Neural Netw. 2025. PMID: 39793491

8

Defining the needle in a haystack: A compendium of genomic, pathologic, and clinical characteristics of rare pulmonary tumors.

Shields MD, Minton KG, Tran M, Gunderman PR, Larsson LG, Guo S, Kniese CM, Wei CX, Marin-Acevedo JA, Maniar R, Durm GA, He W, Hanna NH. Shields MD, et al. Lung Cancer. 2024 Dec 27;199:108035. doi: 10.1016/j.lungcan.2024.108035. Online ahead of print. Lung Cancer. 2024. PMID: 39731864 Review.

9

Perceptions of the impact of individual allergic rhinitis symptoms: A survey of ARIA clinical experts.

Gil-Mata S, Teixeira T, Bedbrook A, Bousquet J, Sousa-Pinto B, Vieira RJ; ARIA group. Gil-Mata S, et al. World Allergy Organ J. 2024 Dec 3;17(12):100999. doi: 10.1016/j.waojou.2024.100999. eCollection 2024 Dec. World Allergy Organ J. 2024. PMID: 39717676 Free PMC article.

10

Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer.

Chakraborty S, Sen U, Ventura K, Jethalia V, Coleman C, Sridhar S, Banerjee A, Ozakinci H, Mahendravarman Y, Snioch K, de Stanchina E, Shields MD, Tomalin LE, Demircioglu D, Boyle TA, Tocheva A, Hasson D, Sen T. Chakraborty S, et al. Among authors: shields md. Cell Rep Med. 2024 Dec 17;5(12):101852. doi: 10.1016/j.xcrm.2024.101852. Epub 2024 Dec 9. Cell Rep Med. 2024. PMID: 39657664 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

968 results

Search Page

Filters